Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Leo's use of the word "promising" sounds very familiar.

We remain eager to learn about Brilacidin’s treatment effect in COVID-19 patients, a possible gateway indication toward evaluating Brilacidin in other acutely infectious viral diseases, building on the type of promising pre-clinical data presented at ASV 2021 by GMU scientists.

Two independent Machine Learning studies identified Brilacidin as one of the most promising inhibitors of SARS-CoV-2, the virus responsible for COVID-19, based on Brilacidin’s molecular properties.

https://www.ipharminc.com/press-release/2021/7/22/innovation-pharmaceuticals-announces-new-in-vitro-data-supporting-brilacidins-broad-spectrum-antiviral-potential-presented-at-the-american-society-of-virologys-annual-meeting

There are many more examples here.

https://www.ipharminc.com/search?q=promising

I rather like this quote: "Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned"